Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6
Wesam Ali, Małgorzata Więcek, Dorota Łażewska, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 740-751
Closed Access | Times Cited: 24

Showing 24 citing articles:

Small molecule selenium-containing compounds: Recent development and therapeutic applications
Hongyan Chuai, San‐Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113621-113621
Closed Access | Times Cited: 166
Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review
Karanvir Singh, Rohit Pal, Shah Alam Khan, et al.
Journal of Molecular Structure (2021) Vol. 1237, pp. 130369-130369
Closed Access | Times Cited: 82
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships
Ravi Kumar, Bhaskar Sahu, Shelly Pathania, et al.
ChemMedChem (2021) Vol. 16, Iss. 12, pp. 1878-1901
Closed Access | Times Cited: 47
Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease
Patryk Pyka, Sabrina Garbo, Rossella Fioravanti, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104062-104062
Open Access | Times Cited: 7
The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
Gniewomir Latacz, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3420-3420
Open Access | Times Cited: 50
Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma
Wesam Ali, Gabriella Spengler, Annamária Kincses, et al.
European Journal of Medicinal Chemistry (2020) Vol. 200, pp. 112435-112435
Open Access | Times Cited: 39
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
Kinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115695-115695
Open Access | Times Cited: 10
Recent Advancements and Developments in the Biological Importance of 1,3,5‐Triazines
Bhagyashri Rathod, Swati Pawar, Sachin Puri, et al.
ChemistrySelect (2024) Vol. 9, Iss. 12
Closed Access | Times Cited: 3
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma
Wesam Ali, Sabrina Garbo, Annamária Kincses, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114761-114761
Closed Access | Times Cited: 15
Recent Advances on the s‐Triazine Scaffold with Emphasis on Synthesis, Structure‐Activity and Pharmacological Aspects: A Concise Review
Ab Majeed Ganai, Tabasum Khan Pathan, Girish A. Hampannavar, et al.
ChemistrySelect (2021) Vol. 6, Iss. 7, pp. 1616-1660
Closed Access | Times Cited: 19
A closer look at N2,6-substituted 1,3,5-triazine-2,4-diamines: Advances in synthesis and biological activities
Muhammad Syafiq Bin Shahari, Anton V. Dolzhenko
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114645-114645
Closed Access | Times Cited: 13
Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo
Sylwia Sudoł, Katarzyna Kucwaj‐Brysz, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112529-112529
Open Access | Times Cited: 19
An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential
Katarzyna Kucwaj‐Brysz, Wesam Ali, Rafał Kurczab, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105695-105695
Closed Access | Times Cited: 11
Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization
Marcin Jakubiec, Michał Abram, Mirosław Zagaja, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 11, pp. 2198-2222
Open Access | Times Cited: 1
Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates
Marcin Jakubiec, Michał Abram, Mirosław Zagaja, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 17, pp. 3228-3256
Open Access | Times Cited: 1
New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants
Marcin Jakubiec, Michał Abram, Mirosław Zagaja, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1862-1862
Open Access | Times Cited: 6
Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach
Lukas Zell, Constanze Lainer, Jakub Kollár, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4435-4435
Open Access | Times Cited: 6
New Triazine Derivatives as Serotonin 5-HT6 Receptor Ligands
Dorota Łażewska, Małgorzata Więcek, Grzegorz Satała, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1108-1108
Open Access | Times Cited: 3
Triazines, Tetrazines, and Fused Ring Polyaza Systems
Marie‐Aude Hiebel, Franck Suzenet
Progress in heterocyclic chemistry (2019), pp. 505-531
Closed Access | Times Cited: 7
Discovery and Profiling of Novel Multi-Mechanistic Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates
Marcin Jakubiec, Michał Abram, Mirosław Zagaja, et al.
(2024)
Closed Access
Organoselenium compounds beyond antioxidants
Ritu Mamgain, Garima Mishra, Saumya Kriti, et al.
Future Medicinal Chemistry (2024), pp. 1-23
Closed Access
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents
Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, Sabina Podlewska, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115756-115756
Open Access | Times Cited: 1
Triazines, tetrazines, and fused ring polyaza systems
Marie‐Aude Hiebel, Franck Suzenet
Progress in heterocyclic chemistry (2021), pp. 467-499
Closed Access | Times Cited: 1
Page 1

Scroll to top